Entity Common Stock, Shares Outstanding of Vitro Biopharma, Inc. from 12 Sep 2011 to 13 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vitro Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 12 Sep 2011 to 13 Feb 2026.
  • Vitro Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Feb 2026 was 4,517,651, a 1.3% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 4,517,651 +57,116 +1.3% 13 Feb 2026 10-K 13 Feb 2026 2025 FY
Q3 2025 4,460,535 0 0% 12 Sep 2025 10-Q 12 Sep 2025 2025 Q3
Q2 2025 4,460,535 0 0% 20 Jun 2025 10-Q 20 Jun 2025 2025 Q2
Q1 2025 4,460,535 0 0% 20 Mar 2025 10-Q 20 Mar 2025 2025 Q1
Q4 2024 4,460,535 +30,000 +0.68% 28 Jan 2025 10-K 28 Jan 2025 2024 FY
Q3 2024 4,460,535 +29,990 +0.68% 16 Sep 2024 10-Q 16 Sep 2024 2024 Q3
Q2 2024 4,460,535 -110,699,645 -96% 30 May 2024 10-Q 31 May 2024 2024 Q2
Q1 2024 4,460,535 -110,699,645 -96% 14 Mar 2024 10-Q 14 Mar 2024 2024 Q1
Q4 2023 4,430,535 29 Jan 2024 10-K 29 Jan 2024 2023 FY
Q3 2023 4,430,545 28 Aug 2023 10-Q 28 Aug 2023 2023 Q3
Q2 2023 115,160,180 13 Jun 2023 10-Q 13 Jun 2023 2023 Q2
Q1 2023 115,160,180 14 Mar 2023 10-Q 14 Mar 2023 2023 Q1
Q3 2016 20,391,822 15 Aug 2016 10-K 22 Sep 2016 2015 FY
Q1 2016 20,391,822 +420,000 +2.1% 15 Mar 2016 10-Q 30 Mar 2016 2015 Q3
Q4 2015 19,971,822 0 0% 30 Dec 2015 10-Q 22 Jan 2016 2015 Q2
Q1 2015 19,971,822 +168,419 +0.85% 15 Mar 2015 10-Q 24 Mar 2015 2015 Q1
Q4 2014 19,971,822 +168,419 +0.85% 12 Feb 2015 10-K 13 Feb 2015 2014 FY
Q3 2014 19,918,346 +114,943 +0.58% 11 Sep 2014 10-Q 22 Sep 2014 2014 Q3
Q2 2014 19,918,346 +114,943 +0.58% 18 Jun 2014 10-Q 19 Jun 2014 2014 Q2
Q1 2014 19,803,403 +494,491 +2.6% 17 Mar 2014 10-Q 17 Mar 2014 2014 Q1
Q4 2013 19,803,403 +494,491 +2.6% 14 Jan 2014 10-K 12 Feb 2014 2013 FY
Q3 2013 19,803,403 +494,491 +2.6% 16 Sep 2013 10-Q 23 Sep 2013 2013 Q3
Q2 2013 19,803,403 +932,186 +4.9% 11 Jun 2013 10-Q 18 Jun 2013 2013 Q2
Q1 2013 19,308,912 +437,695 +2.3% 14 Mar 2013 10-Q 21 Mar 2013 2013 Q1
Q4 2012 19,308,912 +779,917 +4.2% 05 Jan 2013 10-K 12 Feb 2013 2012 FY
Q3 2012 19,308,912 +779,917 +4.2% 14 Sep 2012 10-Q/A 17 Oct 2012 2012 Q3
Q2 2012 18,871,217 14 Jun 2012 10-Q/A 22 Jun 2012 2012 Q2
Q1 2012 18,871,217 15 Mar 2012 10-Q 21 Mar 2012 2012 Q1
Q4 2011 18,528,995 24 Jan 2012 10-K/A 16 Feb 2012 2011 FY
Q3 2011 18,528,995 12 Sep 2011 10-Q/A 12 Oct 2011 2011 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.